Tixel i is a novel, non-invasive device for managing dry eye associated with meibomian gland dysfunction.
It delivers controlled thermal energy to the eyelids, effectively unblocking and resetting glands without the need for ocular shields. Treatments are rapid, typically under one minute per eye, with minimal downtime and long-term results.
Suitable for all skin types, Tixel i can be used as a stand-alone therapy or in conjunction with intense pulsed light for enhanced outcomes. Clinicians benefit from high patient satisfaction, predictable results, and an efficient, evidence-based treatment option that integrates seamlessly into clinical practice.
Visit: tixel.us/dryeye
